Zsz
2021-03-26
Do comment!
5 of Thursday’s 6 IPOs Fall Below Offer Prices
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
5
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":358482747,"tweetId":"358482747","gmtCreate":1616722796889,"gmtModify":1634524364435,"author":{"id":3577162823356617,"idStr":"3577162823356617","authorId":3577162823356617,"authorIdStr":"3577162823356617","name":"Zsz","avatar":"https://static.tigerbbs.com/71f20502a5ac8aec5b0d547f909943cc","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Do comment!</p></body></html>","htmlText":"<html><head></head><body><p>Do comment!</p></body></html>","text":"Do comment!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/358482747","repostId":1122505368,"repostType":4,"repost":{"id":"1122505368","kind":"news","pubTimestamp":1616722520,"share":"https://www.laohu8.com/m/news/1122505368?lang=&edition=full","pubTime":"2021-03-26 09:35","market":"us","language":"en","title":"5 of Thursday’s 6 IPOs Fall Below Offer Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1122505368","media":"barrons","summary":"Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the","content":"<p>Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.</p>\n<p>Shares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at $30.10 and peaked at $38.99. The stock ended Thursday up $16, or 80%, at $36.</p>\n<p>Jay Ritter, a University of Florida professor who studies IPOs, said that Thursday wasn’t a bad day for the market even though five of the six stock sales broke, or fell below their offering prices. Instead, he said, IPOs are being priced closer to the actual value of the stock.</p>\n<p>Since April 1 last year, he said, the average first day gain for IPOs was 38%, Ritter said. “The average first day return this month was down to 10%, including today’s deals,” Ritter told<i>Barron’s</i>.</p>\n<p>Olink raised nearly $353 million,selling 17,647,058 shares at $20 each, comfortably above the range of $16 to $18 it had told investors to expect. All the other five priced their shares at or below the forecasted prices,Goldman,Morgan Stanley,and SVB Leerink are underwriters on the deal.</p>\n<p>Olink, based in Sweden, provides products and services for proteomics research. It reported $6.78 million in losses on $54 million in revenue for 2020,according to its prospectus.</p>\n<p>Vizio Holding (VZIO), a provider of smart TVs, meanwhile, dropped below its $21 IPO price. The stock started off at $17.50, hit a high of $19.49, and closed at $19.10, off more than 9%.</p>\n<p>Vizio’s tepid performance came after the company cut the size of its deal by nearly 19%,selling 12,250,000 shares at $21 each. It had planned to offer 15.12 million shares at between $21 and $23. J.P. Morgan and BofA Securities are underwriters on the deal.</p>\n<p>Vizio has sold 82.2 million televisions and 11.8 million sound bars since its founding in 2002,its prospectus said. The Irving, Calif.-based company is profitable, reporting $102.5 million in earnings on $2 billion in revenue for 2020.</p>\n<p>Vizio will be using proceeds from the IPO to invest in people and technology, Adam Townsend, Vizio’s CFO, told<i>Barrons</i>from the NYSE before trading began.</p>\n<p>When asked about growth, Townsend pointed to the company’s SmartCast platform, which lets users stream programs from services such as Hulu,NetflixandAmazonPrime on the TVs. The SmartCast platform had 12.2 million active accounts at the end of 2020, the prospectus said. SmartCast is becoming an “increasingly bigger part of [Vizio’s) business in terms of revenue growth and profit contribution,” he said.</p>\n<p>Cricut (CRCT) also dropped during its debut Thursday. The stock opened at $15.80, peaked at $18.45, and closed at $17.80, down 11%.</p>\n<p>Cricut raised $306.2 million late Wednesday afterselling about 15.3 million shares at $20 each, the bottom of its $20-to-$22 price range.Goldman Sachsand Morgan Stanley are underwriters on the deal.</p>\n<p>Cricut provides computer-controlled cutting machines that are designed for home crafters or hobbyists. The machines, which sell for between $179.99 to $399.99, help users cut different materials, like paper, vinyl, leather, for craft projects. Cricut also offers accessories like mats and craft tools.</p>\n<p>Cricut is profitable: It reported $154.5 million in income on $959 million in total revenue for 2020, itsprospectus said.</p>\n<p>Shares of SEMrush (SEMR) opened at $11.50, off nearly 18% from its $14 IPO price. The stock hit a high of $12.14 and closed Thursday at $11.22, off nearly 20%.</p>\n<p>Late Wednesday, SEMrush slashed the size of its offering by 40%,selling 10 million shares at $14 each. It had planned to offer 16.8 million shares at $14 to $16 each. Goldman Sachs, J.P. Morgan, Jefferies, and KeyBanc Capital Markets are underwriters on the deal.</p>\n<p>SEMrush provides a software-as-a-service platform that helps companies reach the correct audience for their content, using the appropriate channels and in the right context, its prospectus said. The company isn’t profitable<b>,</b>posting $7 million in losses on $124.9 million in revenue for 2020, theprospectus said.</p>\n<p>Diversey Holdings(DSEY) delivered the biggest deal, but its shares didn’t trade above their $15 IPO price. Diversey’s stock opened at $13.50 and closed at their high of $14.98, off 2 cents.</p>\n<p>Diversey collected $692.3 million afterselling 46,153,846 at $15 each, below its $18-to-$21 price range.Citigroup,Morgan Stanley,Barclays,and J.P. Morgan are underwriters on the deal.</p>\n<p>Diversey provides cleaning chemicals, equipment, and services to customers in the food and beverage, healthcare, and building services industries. The company reported $183.3 million in losses on $2.6 billion in sales for 2020,a prospectus said. Its long-term debt totaled $2.7 billion in 2020.</p>\n<p>Sealed Air(SEE)sold the Diversey businessto Bain Capital in 2017 for about $3.2 billion. Bain will own nearly 76% of the company after the IPO.</p>\n<p>Lastly, LAVA Therapeutics (LVTX) also dropped below its $15 IPO price. Shares opened at $12, peaked at $15.29 and ended down 4.7% at $14.30.</p>\n<p>The company collected $100.5 million afterselling 6.7 million shares at $15 each, in the middle of its $14-to-$16 price range. J.P. Morgan, Jefferies, and SVB Leerink were underwriters on the deal.</p>\n<p>LAVA, a biotech, is developing therapies to treat tumor cell cancers. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of hematologic cancers. The company reported $13.9 million in losses on $3.2 million in revenue in 2020,a prospectus said. It had 31 employees.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 of Thursday’s 6 IPOs Fall Below Offer Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 of Thursday’s 6 IPOs Fall Below Offer Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-26 09:35 GMT+8 <a href=https://www.barrons.com/articles/6-companies-are-making-their-trading-debuts-thursday-51616692763?mod=hp_LEAD_4><strong>barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.\nShares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at...</p>\n\n<a href=\"https://www.barrons.com/articles/6-companies-are-making-their-trading-debuts-thursday-51616692763?mod=hp_LEAD_4\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/6-companies-are-making-their-trading-debuts-thursday-51616692763?mod=hp_LEAD_4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122505368","content_text":"Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.\nShares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at $30.10 and peaked at $38.99. The stock ended Thursday up $16, or 80%, at $36.\nJay Ritter, a University of Florida professor who studies IPOs, said that Thursday wasn’t a bad day for the market even though five of the six stock sales broke, or fell below their offering prices. Instead, he said, IPOs are being priced closer to the actual value of the stock.\nSince April 1 last year, he said, the average first day gain for IPOs was 38%, Ritter said. “The average first day return this month was down to 10%, including today’s deals,” Ritter toldBarron’s.\nOlink raised nearly $353 million,selling 17,647,058 shares at $20 each, comfortably above the range of $16 to $18 it had told investors to expect. All the other five priced their shares at or below the forecasted prices,Goldman,Morgan Stanley,and SVB Leerink are underwriters on the deal.\nOlink, based in Sweden, provides products and services for proteomics research. It reported $6.78 million in losses on $54 million in revenue for 2020,according to its prospectus.\nVizio Holding (VZIO), a provider of smart TVs, meanwhile, dropped below its $21 IPO price. The stock started off at $17.50, hit a high of $19.49, and closed at $19.10, off more than 9%.\nVizio’s tepid performance came after the company cut the size of its deal by nearly 19%,selling 12,250,000 shares at $21 each. It had planned to offer 15.12 million shares at between $21 and $23. J.P. Morgan and BofA Securities are underwriters on the deal.\nVizio has sold 82.2 million televisions and 11.8 million sound bars since its founding in 2002,its prospectus said. The Irving, Calif.-based company is profitable, reporting $102.5 million in earnings on $2 billion in revenue for 2020.\nVizio will be using proceeds from the IPO to invest in people and technology, Adam Townsend, Vizio’s CFO, toldBarronsfrom the NYSE before trading began.\nWhen asked about growth, Townsend pointed to the company’s SmartCast platform, which lets users stream programs from services such as Hulu,NetflixandAmazonPrime on the TVs. The SmartCast platform had 12.2 million active accounts at the end of 2020, the prospectus said. SmartCast is becoming an “increasingly bigger part of [Vizio’s) business in terms of revenue growth and profit contribution,” he said.\nCricut (CRCT) also dropped during its debut Thursday. The stock opened at $15.80, peaked at $18.45, and closed at $17.80, down 11%.\nCricut raised $306.2 million late Wednesday afterselling about 15.3 million shares at $20 each, the bottom of its $20-to-$22 price range.Goldman Sachsand Morgan Stanley are underwriters on the deal.\nCricut provides computer-controlled cutting machines that are designed for home crafters or hobbyists. The machines, which sell for between $179.99 to $399.99, help users cut different materials, like paper, vinyl, leather, for craft projects. Cricut also offers accessories like mats and craft tools.\nCricut is profitable: It reported $154.5 million in income on $959 million in total revenue for 2020, itsprospectus said.\nShares of SEMrush (SEMR) opened at $11.50, off nearly 18% from its $14 IPO price. The stock hit a high of $12.14 and closed Thursday at $11.22, off nearly 20%.\nLate Wednesday, SEMrush slashed the size of its offering by 40%,selling 10 million shares at $14 each. It had planned to offer 16.8 million shares at $14 to $16 each. Goldman Sachs, J.P. Morgan, Jefferies, and KeyBanc Capital Markets are underwriters on the deal.\nSEMrush provides a software-as-a-service platform that helps companies reach the correct audience for their content, using the appropriate channels and in the right context, its prospectus said. The company isn’t profitable,posting $7 million in losses on $124.9 million in revenue for 2020, theprospectus said.\nDiversey Holdings(DSEY) delivered the biggest deal, but its shares didn’t trade above their $15 IPO price. Diversey’s stock opened at $13.50 and closed at their high of $14.98, off 2 cents.\nDiversey collected $692.3 million afterselling 46,153,846 at $15 each, below its $18-to-$21 price range.Citigroup,Morgan Stanley,Barclays,and J.P. Morgan are underwriters on the deal.\nDiversey provides cleaning chemicals, equipment, and services to customers in the food and beverage, healthcare, and building services industries. The company reported $183.3 million in losses on $2.6 billion in sales for 2020,a prospectus said. Its long-term debt totaled $2.7 billion in 2020.\nSealed Air(SEE)sold the Diversey businessto Bain Capital in 2017 for about $3.2 billion. Bain will own nearly 76% of the company after the IPO.\nLastly, LAVA Therapeutics (LVTX) also dropped below its $15 IPO price. Shares opened at $12, peaked at $15.29 and ended down 4.7% at $14.30.\nThe company collected $100.5 million afterselling 6.7 million shares at $15 each, in the middle of its $14-to-$16 price range. J.P. Morgan, Jefferies, and SVB Leerink were underwriters on the deal.\nLAVA, a biotech, is developing therapies to treat tumor cell cancers. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of hematologic cancers. The company reported $13.9 million in losses on $3.2 million in revenue in 2020,a prospectus said. It had 31 employees.","news_type":1},"isVote":1,"tweetType":1,"viewCount":55,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/358482747"}
精彩评论